Modeling airway persistent infection of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 08 03 2024
accepted: 12 04 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 16 5 2024
Statut: epublish

Résumé

Non-typeable

Identifiants

pubmed: 38751999
doi: 10.3389/fcimb.2024.1397940
pmc: PMC11094313
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1397940

Informations de copyright

Copyright © 2024 Ariolli, Canè, Di Fede, Tavarini, Taddei, Buno, Delany, Rossi Paccani and Pezzicoli.

Déclaration de conflit d'intérêts

At the time of the study AA was recipient of a GSK fellowship from the PhD program of the University of Tuscia. MC was a PhD student recipient of a PhD fellowship funded by the MIUR at the University of Naples Federico II. AT is an employee of the University of Tuscia. MD, ST, KB, ID, SP and AP are employees of the GSK group of companies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Andrea Ariolli (A)

Department for Innovation in Biological, Agro-Food and Forest Systems, University of Tuscia, Viterbo, Italy.

Martina Canè (M)

Department of Biology, University of Naples Federico II, Napoli, Italy.

Martina Di Fede (M)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Simona Tavarini (S)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Anna Rita Taddei (AR)

Great Equipment Center-Section of Electron Microscopy, University of Tuscia, Viterbo, Italy.

Kevin Pete Buno (KP)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Isabel Delany (I)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Silvia Rossi Paccani (S)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Alfredo Pezzicoli (A)

GlaxoSmithKline Vaccines s.r.l., Preclinical R&D, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH